← Back to Search

Neurostimulation System

Neurostimulation System for Chronic Pain

N/A
Waitlist Available
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing whether a certain kind of electrical stimulation can help relieve chronic pain for people with certain kinds of medical conditions.

Who is the study for?
This trial is for individuals with chronic pain who can follow the study's procedures. It excludes those with other pain-related conditions or external factors like ongoing litigation or workers' compensation claims that could affect outcome reporting.Check my eligibility
What is being tested?
The study tests how well Boston Scientific's approved neurostimulation systems help manage chronic pain by looking at specific metrics and their link to patient outcomes.See study design
What are the potential side effects?
While not specified here, neurostimulation side effects may include discomfort at the implant site, unwanted changes in stimulation, and potential infection risks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Responder Rate

Trial Design

3Treatment groups
Experimental Treatment
Group I: Boston Scientific SCS Systems (Day 0 SCS Trial Procedure)Experimental Treatment1 Intervention
All commercially approved Boston Scientific neurostimulation systems indicated for the treatment of chronic pain.
Group II: Boston Scientific SCS Systems (Day 0 IPG Activation)Experimental Treatment1 Intervention
All commercially approved Boston Scientific neurostimulation systems indicated for the treatment of chronic pain.
Group III: Boston Scientific SCS Systems (Day 0 Enrollment)Experimental Treatment1 Intervention
All commercially approved Boston Scientific neurostimulation systems indicated for the treatment of chronic pain, except for Precision™ and Precision™ Plus.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurostimulation System
2017
N/A
~550

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
720 Previous Clinical Trials
932,478 Total Patients Enrolled
32 Trials studying Chronic Pain
64,625 Patients Enrolled for Chronic Pain
Roshini Jain, M.S.Study DirectorBoston Scientific Neuromodulation Corporation
3 Previous Clinical Trials
1,764 Total Patients Enrolled
3 Trials studying Chronic Pain
1,764 Patients Enrolled for Chronic Pain
Natalie Bloom Lyons, M.S.Study DirectorBoston Scientific Neuromodulation Corporation
1 Previous Clinical Trials
1,500 Total Patients Enrolled
1 Trials studying Chronic Pain
1,500 Patients Enrolled for Chronic Pain

Media Library

Boston Scientific commercially approved neurostimulation systems (Neurostimulation System) Clinical Trial Eligibility Overview. Trial Name: NCT03240588 — N/A
Chronic Pain Research Study Groups: Boston Scientific SCS Systems (Day 0 SCS Trial Procedure), Boston Scientific SCS Systems (Day 0 IPG Activation), Boston Scientific SCS Systems (Day 0 Enrollment)
Chronic Pain Clinical Trial 2023: Boston Scientific commercially approved neurostimulation systems Highlights & Side Effects. Trial Name: NCT03240588 — N/A
Boston Scientific commercially approved neurostimulation systems (Neurostimulation System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03240588 — N/A
Chronic Pain Patient Testimony for trial: Trial Name: NCT03240588 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locales are currently executing this experiment?

"This medical research is being conducted across 13 distinct sites. These locations, which include Eugene, New Orleans and Carlsbad, are spread throughout the nation in order to facilitate participant accessibility; it is recommended that those interested join the closest trial hub they can find."

Answered by AI

How many test subjects are partaking in this medical experiment?

"Correct. According to clinicaltrials.gov, this investigation is still seeking participants after being posted on July 31st 2017 and revised November 2nd 2022; it requires 1900 volunteers from 13 different locations for the trial's completion."

Answered by AI

Are there any available openings for potential participants in this clinical research?

"Affirmative. Clinicaltrials.gov records demonstrate that this trial, which was initially listed on July 31st 2017, is actively recruiting individuals for participation. The study seeks to enrol 1,900 patients across 13 different sites."

Answered by AI

Who else is applying?

What state do they live in?
Other
Oregon
Florida
California
What site did they apply to?
Willis-Knighton River Cities Clinical Research Center
Pacific Sports and Spine, LLC
Coastal Pain & Spinal Diagnostics
Other
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
1
2
3+

Why did patients apply to this trial?

Looking for anything to help treat my pain. To see if I can find better relief from my stimulator.
PatientReceived no prior treatments
I can’t seem to find anyone to successfully treat my pain. I do not want surgery.
PatientReceived 2+ prior treatments
Have chronic pain. I have tried various medications and treatments and am still in chronic pain.
PatientReceived 1 prior treatment
I have been prescribed gabapentin and meloxicam and had zero relief. I have been diagnosed with ankylosing spondylitis. I am looking for other ways to manage this pain.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

Is there compensation for time spent on the trial?
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems
2017. "NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03240588.
~70 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top